The present invention relates to a pharmaceutical composition comprising a first component comprising dabigatran and a second component comprising an inorganic acidic excipient. It also relates to method of preparing such compositions and using those compositions to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.